{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-009160","form_type":"8-K","ticker":"HSCS","cik":"0001468492","company_name":"HeartSciences Inc.","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.259532+00:00","generated_at":"2026-06-06T13:19:19.133391+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Heart Test Labs gets 180-day Nasdaq bid-price extension; faces delisting if not compliant by July 29, 2024","bullets":["Nasdaq granted additional 180-day extension to July 29, 2024, to regain $1 minimum bid price compliance.","Company previously failed minimum bid price based on 30 consecutive business day closing bid.","If not compliant by deadline, Nasdaq will issue delisting notice; company may appeal.","Company may implement reverse stock split to regain compliance but provides no assurance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-009160","json":"https://secwatch.observer/filing/0000950170-24-009160.json","markdown":"https://secwatch.observer/filing/0000950170-24-009160.md","text":"https://secwatch.observer/filing/0000950170-24-009160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/0000950170-24-009160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/hscs-20240130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T13:19:19.133391+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fe1e9ddc468e3df92bd56b341504c6748fb490b7","claim":"HeartSciences Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).","evidence_excerpt":"January 30, 2024, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day extension to July 29, 2024, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If the Company does not regain compliance within the allotted compliance period, Nasdaq staff will provide notice that the Company’s Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. The Company will continue to monitor the closing bid price of it","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/0000950170-24-009160-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}